Patient Care Pathways Between Ambulatory and Hospital Settings in Mental Health Care
NCT ID: NCT04442880
Last Updated: 2020-06-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
12551 participants
OBSERVATIONAL
2015-07-31
2018-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The primary objective of the study is to identify the organizational factors and the characteristics of mental health care providers and of the surrounding care provision associated with the variability in care pathways for mental health care and in their quality.
The primary endpoint is the organizational factors associated with the different typology of care pathways and with the different levels of quality of care (in a multivariate modelling allowing an adjustment on the other factors).
In order to do so, a cohort of patients will be constituted using French administrative databases. Mental health care consumption will be obtained via data from the ambulatory claims database (SNIIRAM) along with hospital discharge databases for psychiatric care (RIM-P) and non-psychiatric acute care (PMSI-MCO). These databases will be supplemented by other linkable databases in order to describe the clinical and socioeconomic characteristics of the patients and environment, as well as the characteristics of care provision and available health and social care.
All adult patients with a full-time or part-time admission to one of seven public psychiatric hospitals participating to the study or admitted to a private psychiatric hospital located on their health territories will be included in the study. Patients not residing in the health territory of those hospitals included in the study as well as patients treated exclusively in ambulatory care settings will be excluded.
Using data from the database and the opinion of key experts, a classification of care pathways will be established in order to identify the factors associated with the variability of the pathways and their quality with multinomial logistic regressions.
The identification of factors associated with the variability in care pathways will lead to recommendations on how to improve the quality of care and the efficiency of the health care system.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of the "Housing First Program" in Homeless Patients With Severe Mental Disorders in France
NCT01570712
Feasibility and Effectiveness of a Coordinated Healthcare Circuit Dedicated to Patients With Handicap
NCT04991558
Prevalence of Mental Disorder and Somatic Co-morbidities Among Asylum Seekers in Marseille
NCT05423782
Homelessness and Prevalence of Neurodevelopmental Disorders
NCT06869915
Family Interventions iN Dementia Mental Health Environments
NCT06937541
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
While it is not possible to act in the short term on the characteristics of patients or of their living conditions, it seems essential to identify the characteristics of mental health care providers and of the surrounding care on offer associated with the variation in care pathways, as they may be subject to reforms to improve the quality of care.
The primary objective of the study is to identify the organizational factors and the characteristics of mental health care providers and of the surrounding care provision associated with the variability in care pathways for mental health care and in their quality.
The secondary objectives are:
* to define a method to elaborate patients' care pathways;
* to assess the respective quality of each possible pathway;
* to build a typology of care pathways with similar characteristics;
* to describe the variability in care pathways and in their associated quality;
* to identify other factors associated with the variability in care pathways and in their quality (characteristics of the patients and their environment).
The primary endpoint is the organizational factors associated with the different typology of care pathways and with the different levels of quality of care (in a multivariate modelling allowing an adjustment on the other factors).
Secondary endpoints will include:
* Identification of individualized care pathways
* Level of quality of each care pathways in ordered classes
* Typology of similar care pathways, and for each category: proportion of the different care pathways within this category, proportion in each quality level, intensity, frequency and diversity of care
* Clinical and socioeconomic characteristics of patients and of their environment significantly associated with the different typology of care pathways and with the different levels of quality of care (in a multivariate modelling allowing an adjustment to the other factors).
In order to do so, a cohort of patients will be constituted using French administrative databases. Mental health care consumption will be obtained via data from the ambulatory claims database (SNIIRAM) along with hospital discharge databases for psychiatric care (RIM-P) and non-psychiatric acute care (PMSI-MCO). These databases will be supplemented by other linkable databases in order to describe the clinical and socioeconomic characteristics of the patients and environment, as well as the characteristics of care provision and available health and social care.
All adult patients with a full-time or part-time admission to one of seven public psychiatric hospitals participating to the study or admitted to a private psychiatric hospital located on their health territories will be included in the study. Patients not residing in the health territory of those hospitals included in the study as well as patients treated exclusively in ambulatory care settings will be excluded.
Care pathways will first be constructed with an analysis of state sequences. They will then be given a quality level: a group of experts will be appointed to define specific criteria to assess quality. The typology of care pathways will then be constructed via an ascending hierarchical classification based on a distance calculation taking into account the temporal ordering of care and descriptive analysis of the groups obtained. Finally, we will identify factors associated with the variability in care pathways and in their quality using multinomial logistic regressions.
The identification of factors associated with the variability in care pathways and in their quality, in particular factors linked to the organization of mental health care and to the complementary health and health and social care provision, will lead to recommendations on how to improve the quality of care and the efficiency of the health care system. Ultimately, this will contribute to the reduction of geographic and social health inequalities.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Patients treated exclusively on an outpatient basis
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assistance Publique - Hôpitaux de Paris
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Karine CHEVREUL, MD, PhD
Role: STUDY_CHAIR
Assistance Publique - Hôpitaux de Paris
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PREPS-14-0028
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.